Individualized cancer treatment Archives - IPO.se

11 nov 2020 Pressmeddelande

2cureX presents commercial roadmap 2021 – 2023

CEO Ole Thastrup and CBO Maarten van der Linden present 2cureX’s roadmap for commercialization...

13 jul 2020 Pressmeddelande

Avstämningsdag för tilldelning av teckningsoptioner av serie TO1 bestämd till den 17 juli 2020

Som tidigare meddelats har styrelsen i 2cureX AB (“2cureX” eller “Bolaget”) beslutat att vederlagsfritt...

3 jul 2020 Pressmeddelande

2cureX AB expands its Board of Directors with Michael Lutz and Nils Brünner

Michael Lutz and Nils Brünner have been elected to the Board of Directors in...

16 jun 2020 Pressmeddelande

2cureX AB establishes collaboration with Scandion Oncology A/S and Erasmus Medical Centre, Rotterdam, in drug-resistant breast cancer patients

2cureX AB (“2cureX”) today announces that it together with Scandion Oncology A/S, Copenhagen and...